Vor Biopharma Inc. (VOR) earnings
Vor Biopharma Inc. (VOR) reported net income of -$695.98M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$116.91M. Figures as of 18 Nov 2026, 02:32 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Earnings (net income), fiscal 2025
- -$695.98M
- Highest on record
- -$43.34Mfiscal 2020
- Lowest on record
- -$695.98Mfiscal 2025
- Fiscal years on record
- 62020–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.
Vor Biopharma Inc. earnings, in more detail
Across the 6 fiscal years on record (2020–2025), the highest was -$43.34M in fiscal 2020 and the lowest -$695.98M in fiscal 2025.
Earnings (net income) by fiscal year
Vor Biopharma Inc. earnings, year by year
| Fiscal year | Earnings (net income) | Change | Year ended |
|---|---|---|---|
| 2025 | -$695.98M | — | |
| 2024 | -$116.91M | — | |
| 2023 | -$117.86M | — | |
| 2022 | -$92.09M | — | |
| 2021 | -$68.90M | — | |
| 2020 | -$43.34M | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.
How to read it
Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.
Vor Biopharma Inc., figure by figure
- Vor Biopharma Inc. market cap
- Vor Biopharma Inc. revenue
- Vor Biopharma Inc. earnings per share (EPS)
- Vor Biopharma Inc. P/E ratio
- Vor Biopharma Inc. P/S ratio
- Vor Biopharma Inc. P/B ratio
- Vor Biopharma Inc. free cash flow
- Vor Biopharma Inc. operating margin
- Vor Biopharma Inc. dividend
- Vor Biopharma Inc. shares outstanding
- Vor Biopharma Inc. total debt
- Vor Biopharma Inc. cash on hand
- Vor Biopharma Inc. total assets
- Vor Biopharma Inc. return on equity (ROE)
- Vor Biopharma Inc. return on invested capital (ROIC)
Vor Biopharma Inc. (VOR) overview: price, valuation and scorecard
Vor Biopharma Inc. earnings: questions and answers
What is Vor Biopharma Inc.'s net income?
Vor Biopharma Inc. (VOR) reported net income of -$695.98M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$116.91M.
What are the highest and lowest net income figures on record for Vor Biopharma Inc.?
Across the 6 fiscal years on record (2020–2025), the highest was -$43.34M in fiscal 2020 and the lowest -$695.98M in fiscal 2025.
How is Vor Biopharma Inc.'s net income calculated?
Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.
Fiscal years are named for the calendar year they end in.
Learn: earnings
All stocks guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “Vor Biopharma Inc. (VOR) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/VOR/earnings
Underlying data: the company's filings with the SEC and Yahoo Finance.